510(k) K161951
K161951 is an FDA 510(k) premarket notification submitted by Kronus, Inc. for the device "KRONUS Aquaporin-4 Autoantibody (AQP4Ab) ELISA Assay". The FDA issued a decision of Substantially Equivalent on July 22, 2016. The device falls under product code PNI (Aquaporin-4 Autoantibody), a Class II device regulated under 21 CFR 866.5665. Kronus, Inc. has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 22, 2016
- Date Received
- July 15, 2016
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Aquaporin-4 Autoantibody
- Device Class
- Class II
- Regulation Number
- 866.5665
- Review Panel
- IM
- Submission Type
For the determination of autoantibodies to Aquaporin-4 in human serum and plasma. The test may be useful as an aid in the diagnosis of Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorders (NMOSD). The test is not to be used alone and is to be used in conjunction with other clinical and radiological (MRI) laboratory findings.